1.
Indian J Dermatol Venereol Leprol
; 2003 Jan-Feb; 69(1): 25-6
Article
de Anglais
| IMSEAR
| ID: sea-52080
RÉSUMÉ
Twenty patients with Schamberg's disease were started on pentoxifylline (400 mg once daily) for a period of 8 weeks. Improvement was assessed at 2 weekly intervals by two observers independently and graded as mild (< 25%, moderate (25-50%) and marked (>50%). Marked improvement was observed in 10/20(50%) patients. We conclude that pentoxifylline should be considered as first line therapy in all patients with Schamberg's disease.
2.
Indian J Physiol Pharmacol
; 1964 Jan; 8(): 52-9
Article
de Anglais
| IMSEAR
| ID: sea-108383
3.
Article
de Anglais
| IMSEAR
| ID: sea-25960